121 related articles for article (PubMed ID: 12855262)
1. EBAG9/RCAS1 expression in hepatocellular carcinoma: correlation with tumour dedifferentiation and proliferation.
Aoki T; Inoue S; Imamura H; Fukushima J; Takahashi S; Urano T; Hasegawa K; Ogushi T; Ouchi Y; Makuuchi M
Eur J Cancer; 2003 Jul; 39(11):1552-61. PubMed ID: 12855262
[TBL] [Abstract][Full Text] [Related]
2. EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions.
Suzuki T; Inoue S; Kawabata W; Akahira J; Moriya T; Tsuchiya F; Ogawa S; Muramatsu M; Sasano H
Br J Cancer; 2001 Nov; 85(11):1731-7. PubMed ID: 11742495
[TBL] [Abstract][Full Text] [Related]
3. EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer.
Takahashi S; Urano T; Tsuchiya F; Fujimura T; Kitamura T; Ouchi Y; Muramatsu M; Inoue S
Int J Cancer; 2003 Sep; 106(3):310-5. PubMed ID: 12845666
[TBL] [Abstract][Full Text] [Related]
4. A highly polymorphic CA repeat marker at the EBAG9/RCAS1 locus on 8q23 that detected frequent multiplication in breast cancer.
Tsuneizumi M; Nagai H; Harada H; Kazui T; Emi M
Ann Hum Biol; 2002; 29(4):457-60. PubMed ID: 12160478
[TBL] [Abstract][Full Text] [Related]
5. Gene and protein expression of RCAS1 in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Anticancer Res; 2003; 23(6D):4967-71. PubMed ID: 14981953
[TBL] [Abstract][Full Text] [Related]
6. Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer.
Akahira JI; Aoki M; Suzuki T; Moriya T; Niikura H; Ito K; Inoue S; Okamura K; Sasano H; Yaegashi N
Br J Cancer; 2004 Jun; 90(11):2197-202. PubMed ID: 15164121
[TBL] [Abstract][Full Text] [Related]
7. Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker.
Reimer TA; Anagnostopoulos I; Erdmann B; Lehmann I; Stein H; Daniel P; Dörken B; Rehm A
BMC Cancer; 2005 May; 5():47. PubMed ID: 15904507
[TBL] [Abstract][Full Text] [Related]
8. Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma.
Noguchi K; Enjoji M; Nakamuta M; Nakashima M; Nishi H; Choi I; Taguchi K; Kotoh K; Shimada M; Sugimachi K; Tsuneyoshi M; Nawata H; Watanabe T
Cancer Lett; 2001 Jul; 168(2):197-202. PubMed ID: 11403925
[TBL] [Abstract][Full Text] [Related]
9. CD8+ lymphocyte infiltration and apoptosis in hepatocellular carcinoma.
Ikeguchi M; Oi K; Hirooka Y; Kaibara N
Eur J Surg Oncol; 2004 Feb; 30(1):53-7. PubMed ID: 14736523
[TBL] [Abstract][Full Text] [Related]
10. The significance of fibroblast growth factor receptor 2 expression in differentiation of hepatocellular carcinoma.
Harimoto N; Taguchi K; Shirabe K; Adachi E; Sakaguchi Y; Toh Y; Okamura T; Kayashima H; Taketomi A; Maehara Y
Oncology; 2010; 78(5-6):361-8. PubMed ID: 20798558
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning and characterization of mouse EBAG9, homolog of a human cancer associated surface antigen: expression and regulation by estrogen.
Tsuchiya F; Ikeda K; Tsutsumi O; Hiroi H; Momoeda M; Taketani Y; Muramatsu M; Inoue S
Biochem Biophys Res Commun; 2001 Jun; 284(1):2-10. PubMed ID: 11374862
[TBL] [Abstract][Full Text] [Related]
12. 'Nodule-in-nodule' appearance in hepatocellular carcinoma: its significance as a morphologic marker of dedifferentiation.
Kojiro M
Intervirology; 2004; 47(3-5):179-83. PubMed ID: 15383727
[TBL] [Abstract][Full Text] [Related]
13. Expression of MAGE, GAGE and BAGE genes in human liver diseases: utility as molecular markers for hepatocellular carcinoma.
Kobayashi Y; Higashi T; Nouso K; Nakatsukasa H; Ishizaki M; Kaneyoshi T; Toshikuni N; Kariyama K; Nakayama E; Tsuji T
J Hepatol; 2000 Apr; 32(4):612-7. PubMed ID: 10782910
[TBL] [Abstract][Full Text] [Related]
14. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.
Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680
[TBL] [Abstract][Full Text] [Related]
15. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
17. Overrepresentation of the EBAG9 gene at 8q23 associated with early-stage breast cancers.
Tsuneizumi M; Emi M; Nagai H; Harada H; Sakamoto G; Kasumi F; Inoue S; Kazui T; Nakamura Y
Clin Cancer Res; 2001 Nov; 7(11):3526-32. PubMed ID: 11705872
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor-binding fragment-associated gene 9 expression and its clinical significance in human testicular cancer.
Fujimura T; Takahashi S; Urano T; Xiaoqiang L; Ogushi T; Muramatsu M; Ouchi Y; Kitamura T; Homma Y; Inoue S
Int J Urol; 2009 Mar; 16(3):329-32. PubMed ID: 19207611
[TBL] [Abstract][Full Text] [Related]
19. Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance.
Ma HX; Shu QH; Pan JJ; Liu D; Xu GL; Li JS; Ma JL; Jia WD; Yv JH; Ge YS
Tumour Biol; 2015 Jun; 36(6):4235-41. PubMed ID: 25592379
[TBL] [Abstract][Full Text] [Related]
20. Tumor heterogeneity in small hepatocellular carcinoma: analysis of tumor cell proliferation, expression and mutation of p53 AND beta-catenin.
An FQ; Matsuda M; Fujii H; Tang RF; Amemiya H; Dai YM; Matsumoto Y
Int J Cancer; 2001 Aug; 93(4):468-74. PubMed ID: 11477549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
